Jennifer Barrett, Assistant Editor

Trulance (plecanatide) is a once-daily oral treatment for chronic idiopathic constipation in adult patients.

A new CDC report assesses factors that influence pregnant women’s adherence to vaccination coverage recommendations.

The FDA announced the approval of Trulance (plecanatide), Synergy’s once-daily oral treatment for chronic idiopathic constipation (CIC) in adult patients.

The FDA has approved Allergan’s newest topical treatment for persistent facial erythema.

The FDA has approved the first generic version of Xyrem (sodium oxybate) oral solution for patients with narcolepsy under strict safety requirements.

A man was recently sentenced to 57 months of imprisonment for his involvement in a drug trafficking organizations’ conspiracy scheme.

Developed by leading cannabinoid research and development company Axim Biotech, the cannabidiol (CBD) gum is designed to alleviate symptoms of IBS.

The FDA has approved Teva’s Vantrela ER (hydrocodone bitartrate) extended-release tablets.

Sale of Panretin gel tubes approved in the United States due to a drug shortage as a result of a manufacturing issue.

The FDA is allowing the sale of EU-approved Panretin gel (alitretinoin 0.1%) tubes in the United States due to a shortage of the US-approved gel.

Five years after the deadly outbreak, the owner and former head pharmacist of the NECC faces charges for racketeering, mail fraud, and murder.

The new guidelines put forth a looser diagnostic treatment threshold for average and low-risk adults.

A Pennsylvania hospital has agreed to pay $510,000 in fines after an inpatient pharmacist stole controlled substances.

A new report released by the National Academies of Sciences, Engineering, and Medicine (NAS) sets forth an objective offering of key evidence surrounding the benefits and harms of cannabis use.

Continuous glucose monitors (CGMs) may soon be eligible for coverage by the US Centers for Medicare and Medicaid Services (CMS).

Patients with atrial fibrillation are typically prescribed warfarin to mitigate stroke risk.

Other highly ranked services included alcohol screening, aspirin therapy for cardiovascular disease prevention, and colorectal cancer screening.

Despite the NECC's claims that regulations were followed, prosecutors in a Boston court allege the pharmacy's tainted products led to 750 meningitis infections nationwide and 64 deaths and they are putting Barry Cadden, co-founder and former head pharmacist of the NECC, on trial in connection with the outbreak.

Although historically underused, metformin is now being reaffirmed as first-line therapy recommendation for type 2 diabetes. The American College of Physicians (ACP) released the updated clinical practice guidelines in the Annals of Internal Medicine.

Cempra’s community-acquired bacterial pneumonia antibiotic drug rejected by FDA.

Officials with the FDA have rejected new drug applications for Cempra's community-acquired bacterial pneumonia (CABP) antibiotic, according to a press release from Cempra.

The advancements of digital technology in the health care landscape are familiar, but officials with CVS are taking it a step further with a digital strategy that can help broaden community outreach in the event of a natural disaster.

A New Jersey pharmacist pleaded guilty for his role in an illegal drug distribution scheme involving large quantities of oxycodone and other controlled substances.

Heroin and oxycodone topped the list of drugs involved in overdose deaths in recent years, according to a report released by the CDC.

Syringe services programs seek to halt the spread of HIV among injection drug users.

Syringe services programs (SSPs) aim to reduce the spread of HIV among people who inject drugs (PWID), as use of shared needles puts them at high risk of contracting or transmitting the infection.

A sharp rise in opioid-related complications among newborns in rural communities highlights the severity of the opioid epidemic in these areas.

Rubraca is the latest targeted agent that treats cancers caused by specific mutations in a patient’s gene.

Officials with Mylan have announced the launch of generic EpiPen (epinephrine injection, USP) Auto-Injector at half the cost of its brand name counterpart.